Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- RTI: When Will We Finally See a Pullback?
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- Anatomy of Success: Green Mountain Coffee
- The Mega-Rally Rolls On
- Biotechnology ETF Investing 101
- 3 Dividend Stocks at Reasonable Prices
- AWS 5/21: The Beginning of the End for QE
- PFP 5/21: Below the Surface
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/21/2013
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 7.23% |
| FEDERAL MOGU | FDML | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NATUS MEDICA | BABY | 5.27% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
This Zacks #1 Rank (Strong Buy) is also trading with great valuations, even as it pressures the 52-week high.
Company Description
TriMas makes engineered and applied products for a variety of industries. The company is broken down into 5 segments; Packaging, Energy, Aerospace & Defense, Engineered Components and Cequent (recreational products).
Another Surprise
Since being featured as a Zacks Rank Buy in July, TriMas has reported 2 more earnings surprises, bringing the streak to 6. The latest quarterly report came on Oct 28.
Earnings per share came in at 37 cents, beating the estimates by 7 cents. Sales were up 22% to nearly $248 million during the quarter, credited to economic improvements as well as growth initiatives.
Optimistic Outlook
Given the strong quarterly performance, management raised its full-year outlook. TriMas expects to more than double EPS, from $0.43 to between $1.05 and $1.10.
Analysts agree and have pushed the Zacks Consensus Estimate to the high end of that range. Forecasts are calling for $1.10 on average, up 6 cents on the earnings news. Next year's estimates are up 8 cents, to $1.34.
If TriMas hits these projections the annual growth rates will be 156% and 22%, respectively.
A Good Value as Well
Shares of TRS are trading at 12 times the 2011 consensus estimate and with a PEG ratio of only 0.8. TriMas has the best price-to-sales ratio in its peer group, at 0.61 times.
Speaking of peers, the company stacks up very well next to its competitors. The company has an ROE of over 47%, compared to the 7.2% the industry averages.
The Chart
There was some profit taking on the earnings news, but shares quickly bounced back. If they can push past the 52-week high, the bullish trend should continue.
Read the July 13th Feature Here
Bill Wilton is the Aggressive Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Small Cap Trader service
Last Week's Aggressive Growth Zacks Rank Buy Stocks
Avnet, Inc. (AVT) has everything going its way. Shares are skyrocketing, but drastic estimate revisions are keeping valuation enticing.
Also, this Zacks #1 Rank (Strong Buy) has a great earnings history and continues to grow both organically and through acquisition.
Read Full Article.
Coach, Inc. (COH) has the wind at its back as sales and earnings continue to surge in this post-recession environment.
Growth rates and estimates are rising following the latest earnings surprise, keeping valuations at relatively attractive levels for this Zacks #1 Rank (Strong Buy).
Read Full Article.
Flextronics (FLEX) just might have it all. Following the sixth consecutive earnings surprise, management raised its outlook above the consensus estimates at the time.
Growth rates are looking fantastic and valuations are great for this Zacks #1 Rank (Strong Buy).
Read Full Article.
Vitamin Shoppe, Inc. (VSI) continues to post excellent results. The company has topped forecasts in each quarter since its 2009 IPO, recently increasing net income 3 fold.
Thanks to an optimistic and aggressive growth forecasts, analysts continue to raise estimates for this Zacks #1 Rank (Strong Buy).
Read Full Article.
Read the full Snapshot Report on TRS